Cytopenia Management in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Azacitidine in the VIALE-A Study

被引：9
|
作者：
Pratz, Keith W.
DiNardo, Courtney D.
Selleslag, Dominik
Li, Junmin
Yamamoto, Kazuhito
Konopleva, Marina
McDonald, Andrew
Babu, Sunil
Stevens, Don A.
Kantarjian, Hagop M.
Traina, Fabiola
Venditti, Adriano
Mayer, Jiri
Montez, Melissa
Ramsingh, Giridharan
Jin, Huan
Ainsworth, William
Duan, Yinghui
Svensson, Anders Erik
Werner, Michael
Potluri, Jalaja
Jonas, Brian A.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134832
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score-matched analysis
    Wang, Rong
    Zhang, Yi
    Chang, Jie
    Wang, Huafeng
    Lou, Yinjun
    Yang, Min
    Xu, Gaixiang
    Tong, Hongyan
    Xie, Wanzhuo
    Zhou, De
    Wei, Juying
    Mai, Wenyuan
    Ye, Xiujin
    Meng, Haitao
    Jin, Jie
    Zhu, Hong-Hu
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (02)
  • [42] Management of Neutropenia during Venetoclax-Based Combination Treatment in Patients with Newly Diagnosed Acute Myeloid Leukemia
    Pratz, Keith W.
    Wei, Andrew H.
    Pollyea, Daniel A.
    Jonas, Brian A.
    Fiedler, Walter
    Recher, Christian
    Hong, Wan-Jen
    Potluri, Jalaja
    Miller, Catherine
    Roboz, Gail J.
    BLOOD, 2019, 134
  • [43] OMNIVERSE: A Phase 1b/2 Study of Oral Azacitidine Plus Venetoclax in Patients with Relapsed/Refractory (R/R) or Newly Diagnosed (ND) Acute Myeloid Leukemia (AML)
    Ravandi, Farhad
    Carraway, Hetty E.
    Taningco, Lilia
    Dilley, Kimberley
    Laille, Eric
    Gong, Jing
    de Menezes, Daniel Lopes
    Wei, Andrew H.
    BLOOD, 2021, 138
  • [44] A Phase 2 Randomized Study Comparing Venetoclax and Azacitidine to Conventional Induction Chemotherapy for Newly Diagnosed Fit Adults with Acute Myeloid Leukemia
    Fathi, Amir T.
    Fell, Geoffrey G.
    El-Jawahri, Areej
    Perl, Alexander E.
    Jonas, Brian A.
    Dias, Ajoy L.
    Mims, Alice S.
    Borate, Uma
    Ragon, Brittany Knick
    Grunwald, Michael R.
    Peters, Mary Linton B.
    Graubert, Timothy A.
    Amrein, Philip C.
    Hock, Hanno R.
    Brunner, Andrew M.
    Hobbs, Gabriela S.
    Narayan, Rupa
    Neuberg, Donna S.
    Aldoss, Ibrahim
    BLOOD, 2022, 140 : 3284 - 3286
  • [45] Outpatient Low-Dose Venetoclax Plus Azacitidine Vs. Intensive Chemotherapy for Newly Diagnosed Fit Patients with Acute Myeloid Leukemia in a Limited Resource Setting
    Lopez-Garcia, Yadith Karina
    De La Garza, Fernando
    De la Rosa-Flores, Gerardo Alexis
    Coronado Alejandro, Edgar Ulises
    Vega-Mateos, Antonio
    Tejada Vasquez, Ana Cristina
    Garcia-Salas, Gerardo
    Garcia-Zarate, Valeria
    Colunga-Pedraza, Perla R. Rocio
    Gomez-Almaguer, David
    Gomez-De Leon, Andres
    BLOOD, 2023, 142
  • [46] Changes in health-related quality of life in patients with newly diagnosed acute myeloid leukemia receiving ivosidenib plus azacitidine or placebo plus azacitidine.
    Schuh, Andre C.
    De Botton, Stephane
    Recher, Christian
    Polo, Susana Vives
    Zarzycka, Ewa
    Wang, Jianxiang
    Bertani, Giambattista
    Heuser, Michael
    Calado, Rodrigo T.
    Yeh, Su-Peng
    Hui, Jianan
    Pandya, Shuchi Sumant
    Gianolio, Diego A.
    Chamberlain, Christina X.
    Dohner, Hartmut
    Montesinos, Pau
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19024 - E19024
  • [47] Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study
    De la Garza-Salazar, Fernando
    Colunga-Pedraza, Perla Rocio
    Gomez-Almaguer, David
    Garcia-Zarate, Valeria Abigail
    Gomez-De Leon, Andres
    LEUKEMIA RESEARCH, 2023, 133
  • [48] A Phase II Study of Azacitidine and Venetoclax as Maintenance Therapy in Patients With Acute Myeloid Leukemia
    Bazinet, Alexandre
    Kantarjian, Hagop
    Borthakur, Gautam
    Yilmaz, Musa
    Bose, Prithviraj
    Jabbour, Elias
    Alvarado, Yesid
    Chien, Kelly
    Pemmaraju, Naveen
    Takahashi, Koichi
    Short, Nicholas
    Daver, Naval
    Issa, Ghayas
    Jain, Nitin
    Bull-Linderman, Debra
    DiNardo, Courtney
    Montalban-Bravo, Guillermo
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S239 - S240
  • [49] Low-dose venetoclax combined with azacitidine in older and frail patients with newly diagnosed acute myeloid leukaemia
    Rong, Chunmeng
    Yang, Fang
    Chen, Yalu
    Wang, Ming
    Ai, Cheng
    Luo, Yuqing
    Gao, Panpan
    Weng, Yiqin
    Huang, Xiaguang
    Gu, Meier
    Huang, Weiping
    Xia, Yongming
    ONCOLOGY LETTERS, 2024, 27 (05)
  • [50] Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia
    Ivanov, Vladimir
    Yeh, Su-Peng
    Mayer, Jiri
    Saini, Lalit
    Unal, Ali
    Boyiadzis, Michael
    Hoffman, David M.
    Kang, Kingston
    Addo, Sadiya N.
    Mendes, Wellington L.
    Fathi, Amir T.
    FUTURE ONCOLOGY, 2022, 18 (26) : 2879 - 2889
12345